Quantcast

Latest Ribbon symbolism Stories

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...

2014-04-07 12:40:36

Obese male mice and normal weight female mice produce female pups that are overweight at birth and in childhood, and have increased number of "terminal end buds" in their breast tissue — the site where cancer often develops in rodents. The findings, presented by a Georgetown Lombardi Comprehensive Cancer Center researcher at the AACR Annual Meeting 2014, come from one of the first animal studies to examine the impact of paternal obesity on future generations' cancer risk. In addition,...

2014-04-07 12:33:35

The Most Promising Emerging Agents in Development for Triple Negative Breast Cancer Target Only Specific Patient Subsets, According to Findings from Decision Resources Group BURLINGTON, Mass., April 7, 2014 /PRNewswire/ -- Decision Resources Group finds that due to the heterogeneity of triple negative breast cancer the most promising emerging agents in development, target only specific subsets of patients. The two novel emerging therapies niraparib (Tesaro) and Xtandi (Medivation/Astellas)...

2014-04-06 12:20:19

INDIANAPOLIS, April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies - including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 - that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 - 9. "Harnessing Breakthroughs - Targeting Cures" is the theme of this year's...

2014-04-05 23:01:13

RF Safe's pink cell phone radiation shields are great for supporting fundraising events for breast cancer awareness. Doctors say keeping cell phones tucked in bras possibly causes breast cancer in young women. Boston, MA (PRWEB) April 05, 2014 RF Safe claims a research team, led by Dr. Lisa Bailey, and one of California’s top breast surgeons, studied four young women – aged from 21 to 39 years old – with multifocal invasive breast cancer that appears to be caused from cell phone...

2014-04-04 23:40:49

Dr. Vera Packard, Executive Director of HERS Breast Cancer Foundation, has been invited by Silicon Valley Business Journal to participate as a mentor in their BizWomen: Mentoring Monday event on April 7. Fremont, Calif. (PRWEB) April 03, 2014 HERS Breast Cancer Foundation today announced that their Executive Director, Dr. Vera Packard, will participate as a mentor in Silicon Valley Business Journal’s national networking event on Monday, April 7. BizWomen: Mentoring Monday is an exciting...

2014-04-04 23:36:36

Active research in breast cancer is producing novel targeted drugs at a rapid pace. Thousand Oaks, California (PRWEB) April 03, 2014 As the Cancer society continues research for breast cancer, several options have emerged. Of these options three drugs have been approved by the FDA for usage as treatment and no one is more excited than Dr. Mai Brooks. Perjeta (pertuzumab) In September 2013, the FDA approved Perjeta for use in combination with Herceptin (trastuzumab) and docetaxel for the...

2014-04-04 23:34:52

Cianna Medical, Inc.: Strut-based breast cancer radiation treatment could expand options for DCIS patients. Aliso Viejo, Calif. (PRWEB) April 03, 2014 Cianna Medical, Inc., a women’s health company, today announced the results of a retrospective study of breast cancer patients with ductal carcinoma in situ (DCIS) treated with SAVI® breast brachytherapy. Researchers reported excellent local control, with recurrence rates that appear to be equivalent to those expected for whole...

2014-04-04 12:27:16

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w9vbt8/global ) has announced the addition of the "Global Mammography Equipment Market 2014-2018" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The analysts forecast the Global Mammography Equipment market to grow at a CAGR of 9.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence...

2014-04-03 12:56:51

Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30 years of follow-up, compared with women who were not treated with these medications, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. "We wanted to evaluate the long-term relationship of fertility medications and breast cancer risk...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related